Photo taken from Katy Rezvani/X
Jun 26, 2024, 04:50
Addition of CD28 enhance CAR NK function in blood and solid tumors – MD Anderson Cancer Center
MD Anderson Cancer Center shared a post on X:
“Research led by Dr. Katy Rezvani found that the addition of CD28, a molecule that is normally absent in mature NK cells, can enhance CAR NK function in blood and solid tumors.
Read how this could enhance NK cell therapies here.”
Source: MD Anderson Cancer Center/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 3, 2024, 13:26
Dec 3, 2024, 11:53
Dec 3, 2024, 11:50
Dec 3, 2024, 11:43